|
Category: pharmaceuticals / chemical synthisis
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Melting Point: | 218.00 °C. @ 760.00 mm Hg
|
| Boiling Point: | 255.00 °C. @ 760.00 mm Hg (est)
|
| Vapor Pressure: | 0.008650 mmHg @ 25.00 °C. (est) |
| Flash Point: | 186.00 °F. TCC ( 85.60 °C. ) (est)
|
| logP (o/w): | 1.054 (est) |
| Soluble in: |
| | water, 2.50E+05 mg/L @ 25 °C (exp) | | | water, 1e+006 mg/L @ 25 °C (est) |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
intravenous-cat LDLo 60 mg/kg CARDIAC: OTHER CHANGES Medecine Vol. 9, Pg. 59, 1930.
intravenous-dog LDLo 70 mg/kg LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Medecine Vol. 9, Pg. 59, 1930.
parenteral-frog LDLo 440 mg/kg Manshu Igaku Zasshi. Manchuria Medical Journal. Vol. 3, Pg. 1, 1925.
intravenous-guinea pig LD50 98 mg/kg PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE
BEHAVIORAL: EXCITEMENT Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 59, Pg. 355, 1963.
intraperitoneal-hamster LDLo 350 mg/kg CARDIAC: OTHER CHANGES Medecine Vol. 9, Pg. 59, 1930.
intraperitoneal-mouse LD50 242 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 158, Pg. 135, 1967.
intravenous-mouse LD50 95 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 95, Pg. 336, 1949.
oral-mouse LD50 400 mg/kg Journal of Medicinal Chemistry. Vol. 9, Pg. 966, 1966.
parenteral-mouse LDLo 500 mg/kg Manshu Igaku Zasshi. Manchuria Medical Journal. Vol. 3, Pg. 1, 1925.
intramuscular-rabbit LD50 175 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 86, Pg. 284, 1946.
intravenous-rabbit LD50 65 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 95, Pg. 336, 1949.
intraperitoneal-rat LD50 165 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 86, Pg. 284, 1946.
intravenous-rat LD50 69 mg/kg Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 33, Pg. 80, 1944.
|
| Dermal Toxicity: |
subcutaneous-dog LDLo 220 mg/kg LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Medecine Vol. 9, Pg. 59, 1930.
subcutaneous-frog LDLo 400 mg/kg LUNGS, THORAX, OR RESPIRATION: DYSPNEA
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE Medecine Vol. 9, Pg. 59, 1930.
subcutaneous-guinea pig LD50 192 mg/kg PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE
BEHAVIORAL: EXCITEMENT Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 59, Pg. 355, 1963.
subcutaneous-mouse LD50 40870 ug/kg BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
BEHAVIORAL: EXCITEMENT Journal of Pharmacology and Experimental Therapeutics. Vol. 87, Pg. 214, 1946.
subcutaneous-rabbit LD50 165 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 86, Pg. 284, 1946.
subcutaneous-rat LD50 1150 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 95, Pg. 336, 1949.
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | pharmaceuticals / chemical synthisis |
| Recommendation for (1R,2S)-(-)-ephedrine hydrochloride usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for (1R,2S)-(-)-ephedrine hydrochloride flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
| | (1R,2S)-2-(methylamino)-1-phenylpropan-1-ol;hydrochloride |
| NIST Chemistry WebBook: | Search Inchi |
| Canada Domestic Sub. List: | 50-98-6 |
| Pubchem (cid): | 65326 |
| Pubchem (sid): | 135022311 |
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| | altusin | | | benzenemethanol, a-[(1S)-1-(methylamino)ethyl]-, (aR)-, hydrochloride (1:1) | | | bronkotabs | | (-)- | ephedrine hydrochloride | | (1R,2S)- | ephedrine hydrochloride | | L-erythro- | ephedrine hydrochloride | | | ephedroguent | | | ephedronguent | | L- | erythro-2-(Methylamino)-1-phenylpropan-1-ol hydrochloride | | (1R,2S)-(-)-2- | methylamino-1-phenyl-1-propanol hydrochloride | | (1R,2S)-2-( | methylamino)-1-phenyl-1-propanol hydrochloride (1:1) | | (1R,2S)-2-( | methylamino)-1-phenylpropan-1-ol hydrochloride (1:1) | | (1R,2S)-2-( | methylamino)-1-phenylpropan-1-ol;hydrochloride | | [R-(R*,S*)]-a-[1-( | methylamino)ethyl]benzenemethanol hydrochloride | | (1R,2S)-a-[1-( | methylamino)ethyl]benzyl alcohol hydrochloride | | | primatene tablets | | | quadrinal | | | sanedrine | | | tedral |
Articles:
|